HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Noribogaine reduces nicotine self-administration in rats.

Abstract
Noribogaine, a polypharmacological drug with activities at opioid receptors, ionotropic nicotinic receptors, and serotonin reuptake transporters, has been investigated for treatment of substance abuse-related disorders. Smoking cessation has major benefits for both individuals and society, therefore the aim of this study was to evaluate the potential of noribogaine for use as a treatment for nicotine dependence. Adult male Sprague-Dawley rats were trained to self-administer nicotine intravenous. After initial food pellet training, followed by 26 sessions of nicotine self-administration training, the rats were administered noribogaine (12.5, 25 or 50 mg/kg orally), noribogaine vehicle, varenicline or saline using a within-subject design with a Latin square test schedule. Noribogaine dose-dependently decreased nicotine self-administration by up to 64% of saline-treated rats' levels and was equi-effective to 1.7 mg/kg intraperitoneal varenicline. Noribogaine was less efficient at reducing food pellets self-administration than at nicotine self-administration, inhibiting the nondrug reinforcing effects of palatable pellets by 23% at the highest dose. These results suggest that noribogaine dose-dependently attenuates drug-taking behavior for nicotine, attenuates the reinforcing effects of nicotine and is comparable to varenicline power in that regard. The findings from the present study hold promise for a new therapy to aid smoking cessation.
AuthorsQing Chang, Taleen Hanania, Deborah C Mash, Emeline L Maillet
JournalJournal of psychopharmacology (Oxford, England) (J Psychopharmacol) Vol. 29 Issue 6 Pg. 704-11 (Jun 2015) ISSN: 1461-7285 [Electronic] United States
PMID25995321 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© The Author(s) 2015.
Chemical References
  • Receptors, Nicotinic
  • Ibogaine
  • Nicotine
  • noribogaine
  • Varenicline
Topics
  • Animals
  • Dose-Response Relationship, Drug
  • Ibogaine (analogs & derivatives, pharmacology)
  • Male
  • Nicotine (administration & dosage)
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, Nicotinic (metabolism)
  • Self Administration (methods)
  • Smoking Cessation (methods)
  • Tobacco Use Disorder (drug therapy, metabolism)
  • Varenicline (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: